SPRO
Spero Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.26
+0.00 (+0.00%)
Rating:A-
Company Profile
CEO
Esther Rajavelu
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.25
Prev. Close
$2.26
Day Low
$2.25
Day High
$2.33
52W Low
$1.80
52W High
$3.22
Market Cap
$0.13B
Volume
0.52M